{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T10:55:05Z","timestamp":1682420105271},"reference-count":6,"publisher":"Informa UK Limited","issue":"5","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Pharmacotherapy"],"published-print":{"date-parts":[[2023,3,24]]},"DOI":"10.1080\/14656566.2023.2192867","type":"journal-article","created":{"date-parts":[[2023,3,16]],"date-time":"2023-03-16T18:23:51Z","timestamp":1678991031000},"page":"665-665","update-policy":"http:\/\/dx.doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":1,"title":["Intravenous immunoglobulin (Gamunex\u00ae 10%) is licensed for the treatment of severe acute exacerbations of myasthenia gravis"],"prefix":"10.1080","volume":"24","author":[{"given":"Francesc","family":"Camps","sequence":"first","affiliation":[{"name":"Medical Affairs, Neurology-Immunology, Grifols. Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Howard W","family":"Sander","sequence":"additional","affiliation":[{"name":"Medical Affairs, Neurology-Immunology, Grifols SSNA, RTP, NC, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[{"name":"Medical Affairs, Neurology-Immunology, Grifols. Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2023,3,21]]},"reference":[{"key":"cit0001","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2022.2122710"},{"key":"cit0002","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000002790"},{"key":"cit0003","unstructured":"Heads of Medicines Agencies (HMA) Gamunex. Product details | DE\/H\/0473\/001. Final SPC. cited 2023 Jan 09, Available at: https:\/\/mri.cts-mrp.eu\/portal\/details?productnumber=DE\/H\/0473\/001"},{"key":"cit0004","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000256698.69121.45"},{"key":"cit0005","doi-asserted-by":"publisher","DOI":"10.1159\/000502818"},{"key":"cit0006","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e31821e5505"}],"container-title":["Expert Opinion on Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14656566.2023.2192867","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,13]],"date-time":"2023-04-13T14:54:22Z","timestamp":1681397662000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14656566.2023.2192867"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,21]]},"references-count":6,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,3,24]]}},"alternative-id":["10.1080\/14656566.2023.2192867"],"URL":"https:\/\/doi.org\/10.1080\/14656566.2023.2192867","relation":{},"ISSN":["1465-6566","1744-7666"],"issn-type":[{"value":"1465-6566","type":"print"},{"value":"1744-7666","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,21]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-03-21","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}